Novo Nordisk Operating Expenses 1988-2025 | NVO
Novo Nordisk annual/quarterly operating expenses history and growth rate from 1988 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Novo Nordisk operating expenses for the quarter ending June 30, 2025 were $6.602B, a 8.61% increase year-over-year.
- Novo Nordisk operating expenses for the twelve months ending June 30, 2025 were $24.689B, a 16.14% increase year-over-year.
- Novo Nordisk annual operating expenses for 2024 were $23.499B, a 24.79% increase from 2023.
- Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
- Novo Nordisk annual operating expenses for 2022 were $14.464B, a 10.65% increase from 2021.
| Novo Nordisk Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $23,499 |
| 2023 | $18,831 |
| 2022 | $14,464 |
| 2021 | $13,071 |
| 2020 | $11,156 |
| 2019 | $10,424 |
| 2018 | $9,875 |
| 2017 | $9,529 |
| 2016 | $9,414 |
| 2015 | $8,702 |
| 2014 | $9,684 |
| 2013 | $9,275 |
| 2012 | $8,390 |
| 2011 | $8,218 |
| 2010 | $7,468 |
| 2009 | $6,898 |
| 2008 | $1,548 |
| 2007 | $6,111 |
| 2006 | $5,023 |
| 2005 | $4,355 |
| 2004 | $3,779 |
| 2003 | $3,072 |
| 2002 | $2,839 |
| 2001 | $2,261 |
| 2000 | $2,076 |
| 1999 | $1,952 |
| 1998 | $23,766 |
| 1997 | $2,096 |
| 1996 | $2,149 |
| 1995 | $2,168 |
| 1994 | |